See up to 3 months of IMA. The 7-day demo opens the 1M and 3M ranges and puts IMA on your watchlist.
Start 7-day demoLatest IMA insider trades
About ImageneBio, Inc. (IMA)
The SEC lists ImageneBio, Inc. under CIK 0001835579, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
IMA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 3,196 | $17K |
| Grant or award | 6 | 802,000 | |
| Option exercise | 2 | 76,752 | |
IMA insider transactions (Form 4)
4720 Form 4 filings on record, the earliest from Jul 25, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kristin Yarema - Officer | Grant or award | Common Stock | 254,800 footnote F1 | $0.00 | - | |
| Kristin Yarema - Officer | Grant or award | Employee Stock Option (right to buy) | 137,200 | $0.00 | - | |
| Kristin Yarema - Officer | Grant or award | Employee Stock Option (Right to Buy) | 250,000 | $0.00 | - | |
| ||||||
| Yanina Grant-Huerta - Officer | Grant or award | Common Stock | 65,000 footnote F2 | $0.00 | - | |
| Yanina Grant-Huerta - Officer | Grant or award | Common Stock | 39,000 footnote F2 | $0.00 | - | |
| Yanina Grant-Huerta - Officer | Grant or award | Employee Stock Option (right to buy) | 56,000 | $0.00 | - | |
| ||||||
| Kristin Yarema - Officer | Option exercise | Common Stock | 38,376 | $0.00 | - | |
| Kristin Yarema - Officer | Other | Common Stock | 115,129 footnote F1 | $0.00 | - | |
| Kristin Yarema - Officer | Option exercise | Restricted Stock Units | 38,376 | $0.00 | - | |
| Kristin Yarema - Officer | Other | Restricted Stock Units | 115,129 | $0.00 | - | |
| ||||||
| Robert B. Lally - Officer | Open-market sale | Common Stock | 1,671 | $5.50 footnote F1 | $9K | |
| Robert B. Lally - Officer | Open-market sale | Common Stock | 1,525 | $5.34 footnote F2 | $8K | |
| ||||||
| Jonathan Jian Wang | Grant or award | Stock Option (right to buy) | 15,600 | $0.00 | - | |
 Otello Stampacchia | Grant or award | Stock Option (right to buy) | 15,600 | $0.00 | - | |
| Joseph P. Slattery | Grant or award | Stock Option (right to buy) | 15,600 | $0.00 | - | |
| David P. Bonita | Grant or award | Stock Option (right to buy) | 15,600 | $0.00 | - | |
| David P. Bonita - Director | Open-market purchase | Pre-Funded Warrants (right to buy) | 336,603 | - footnote F1 | - | |
| David P. Bonita - Director | Open-market purchase | Pre-Funded Warrants (right to buy) | 384,689 | - footnote F1 | - | |
| ||||||
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Pre-Funded Warrants (right to buy) | 336,603 | - footnote F1 | - | |
| ORBIMED ADVISORS LLC - Director | Open-market purchase | Pre-Funded Warrants (right to buy) | 384,689 | - footnote F1 | - | |
| ||||||
| Kristin Yarema - Officer | Grant or award | Common Stock | 85,400 footnote F1 | $0.00 | - | |
| Kristin Yarema - Officer | Grant or award | Employee Stock Option (right to buy) | 128,100 | $0.00 | - | |
| ||||||
| David P. Bonita | Option exercise | Common Stock | 379 | - | - | |
| David P. Bonita | Open-market purchase | Common Stock | 83,611 | $29.90 | $2.50M | |
| David P. Bonita | Option exercise | Stock Option (right to buy) | 17,520 | $0.00 | - | |
| Otello Stampacchia | Option exercise | Common Stock | 379 | - | - | |
| Otello Stampacchia | Open-market purchase | Common Stock | 267,556 | $29.90 | $8.00M | |
| Otello Stampacchia | Option exercise | Stock Option (right to buy) | 17,520 | $0.00 | - | |
| Jotin Marango - Officer | Grant or award | Common Stock | 15,776 | - | - | |
| Jotin Marango - Officer | Tax withholding / forfeiture | Common Stock | 4,630 | $17.16 | $79K | |
| Jotin Marango - Officer | Derivative | Stock Option (Right to Buy) | 181,000 | $0.00 | - | |
| Jotin Marango - Officer | Derivative | Stock Option (Right to Buy) | 105,000 | $0.00 | - | |
| Jotin Marango - Officer | Derivative | Stock Option (Right to Buy) | 397,199 | $0.00 | - | |
| Kristin Yarema - Officer | Grant or award | Employee Stock Option (Right to Buy) | 460,515 | $0.00 | - | |
| Kristin Yarema - Officer | Grant or award | Restricted Stock Units | 153,505 | $0.00 | - | |
| Yufang Lu - Officer | Grant or award | Employee Stock Option (right to buy) | 38,137 | - | - | |
| Yufang Lu - Officer | Grant or award | Employee Stock Option (right to buy) | 27,459 | - | - | |
| Yufang Lu - Officer | Grant or award | Employee Stock Option (right to buy) | 4,591 | - | - | |
| Yufang Lu - Officer | Grant or award | Employee Stock Option (right to buy) | 6,102 | - | - | |
| Erin Butler - Officer | Grant or award | Common Stock | 3,051 | - | - | |
| Erin Butler - Officer | Grant or award | Employee Stock Option (right to buy) | 3,813 | - | - | |
| Jonathan Jian Wang | Grant or award | Common Stock | 143,832 | - | - | |
| Jonathan Jian Wang | Grant or award | Common Stock | 971,173 | - | - | |
| ORBIMED ADVISORS LLC - Director | Grant or award | Common Stock | 83,611 | $2.49 | $208K | |
 Stephen Hui Wang | Grant or award | Common Stock | 188,042 | - | - | |
| Stephen Hui Wang | Grant or award | Common Stock | 50,144 | - | - | |
| Stephen Hui Wang | Grant or award | Common Stock | 12,535 | - | - | |
Item 2.02, 9.01
Item 5.02, 8.01, 9.01
Item 5.02
Item 5.02, 5.07, 9.01
IMA insider trading FAQ
What is the latest insider trade for IMA?
ImageneBio, Inc. (IMA) had 4 insider filings in the last 90 days, with the most recent on 2026-08-17. The full record for IMA runs to 20 Form 4 filings, the earliest from 2025-07-25. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IMA stock?
No insider purchases of IMA were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling IMA stock?
2 insider sales of IMA were filed in the last 90 days, totaling $17K.
Where can I see IMA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IMA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kristin Yarema view on EDGAR
- - Yanina Grant-Huerta view on EDGAR
- - Kristin Yarema view on EDGAR
- - Robert B. Lally view on EDGAR
- - Jonathan Jian Wang view on EDGAR
- - Otello Stampacchia view on EDGAR
- - Joseph P. Slattery view on EDGAR
- - David P. Bonita view on EDGAR
- - David P. Bonita view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where IMA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IMA with a 7-day demo
- IMA on your watchlist
- Every IMA Form 4 filing on record
- Up to 3 months of IMA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
